{
  "schema_version": 1,
  "case_id": "identity.a_h.explicit_a_share.v1",
  "scenario": "multi_market_identity",
  "prompt": "只分析 A 股恒瑞医药，给出最新财务与行业证据。",
  "history": [],
  "data_snapshot": "fixtures/identity/a_h_hengrui.v1.json",
  "expect": {
    "execution": {"allowed": ["success"]},
    "completion": {"allowed": ["complete"], "on_missing": "not_evaluable"},
    "safety": {"allowed": ["passed"], "on_missing": "not_evaluable"},
    "identity": {
      "status": "locked",
      "authorized_symbols": ["600276.SH"],
      "forbidden_symbols": ["01276.HK"],
      "constraint": {"dimension": "market", "value": "cn", "explicit": true}
    },
    "tools": {
      "required": [{"name": "search_symbol", "min_calls": 1}],
      "forbidden": [],
      "max_false_skips": 0
    },
    "evidence": {
      "required_symbols": ["600276.SH"],
      "forbidden_issue_codes": ["numeric_claim_conflict", "unsourced_symbol_figures"]
    },
    "budget": {
      "max_llm_calls": 8,
      "max_input_tokens": 150000,
      "max_iterations": 10,
      "max_visible_tools": null,
      "max_tool_schema_tokens": null
    },
    "risk": {"forbidden_successful_tools": [], "max_authorization_bypasses": 0}
  }
}